Remimazolam Consumption: TCI vs. Manual Infusion
ConditionMoyamoya Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSeoul National University Hospital
About this trial
The purpose of this prospective randomized controlled trial is to compare the total consumption of remimazolam between two different administration methods-Target-Controlled Infusion (TCI) and manual infusion-in patients undergoing cerebrovascular bypass surgery.
Eligibility criteria
Qualifiers
Patients scheduled to undergo cerebrovascular bypass surgery under general anesthesia.
American Society of Anesthesiologists (ASA) Physical Status 1, 2, or 3
Adults aged 19 years or older
Patients who have provided prior written informed consent to participate in the study
Disqualifiers
Patients who do not consent to participate in the research
Patients classified as ASA Physical Status 4
Patients with a BMI ≤18.5 kg/m2 or 35.0 ≥ kg/m2
History of allergy to benzodiazepine-class medications
Trial design
Treatments tested in this trial
- Target-Controlled Infusion (TCI) of Remimazolam
- Manual Infusion of Remimazolam
Treatment groups
58 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov